2m 2m 2m 2m 2m 2m 2m
PROPANC BIOPHRM (PPCB)
NASDAQ
$1.78+$0.15 (+8.93%)
Price as of Jun 04, 2026 4:35 AM EDT- $4.1MMarket Cap
- -100.00%1-Year Change
- BiotechnologyIndustry
PROPANC BIOPHRM (PPCB)
$1.78+$0.15 (+8.93%)
Annual
Quarterly
06/30/2025 | 06/30/2024 | 06/30/2023 | 06/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -223,721 -9.83% | -248,102 +0.07% | -247,919 -3.18% | -256,052 +10.87% | |
Depreciation and Amortization Expense | N/A N/A | 297 -82.16% | 1,665 -16.46% | 1,993 0.00% | |
Total Operating Expenses | 57.3M +3,628.93% | 1.5M -13.54% | 1.8M -10.76% | 2.0M +9.86% | |
Operating Profit | -57.3M +3,628.93% | -1.5M -13.54% | -1.8M -10.76% | -2.0M +9.86% | |
Interest Income | 9 -85.00% | 60 +66.67% | 36 -99.36% | 5,613 +561,200.00% | |
Interest Expense | N/A N/A | N/A N/A | -532,821 -6.33% | -568,798 +26.55% | |
Interest Income and Expense and Net | 9 -85.00% | 60 +100.01% | -532,785 -5.40% | -563,185 +25.30% | |
Total Nonoperating Income and Expense | -1.6M +297.76% | -413,611 -59.20% | -1.0M +40.37% | -722,194 +120.71% | |
Income before Taxes | -58.9M +2,922.23% | -1.9M -30.13% | -2.8M +2.85% | -2.7M +26.82% | |
Income Taxes | N/A N/A | -129,132 -0.55% | -129,841 +136.17% | -54,977 -51.53% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -58.9M +3,136.60% | -1.8M -31.57% | -2.7M +0.09% | -2.7M +9.94% | |
Net Income from Continuing Operations Applicable to Common | -58.9M +2,826.43% | -2.0M -35.61% | -3.1M -6.90% | -3.4M +38.91% | |
Basic EPS and Net Income | -14.85 +74,150.00% | -0.02 -98.89% | -1.80 +3,500.00% | -0.05 -93.75% | |
Diluted EPS and Net Income | -14.85 +74,150.00% | -0.02 -98.89% | -1.80 +3,500.00% | -0.05 -93.75% | |
Basic Weighted Average Shares | 4.0M -95.33% | 85.0M +4,791.03% | 1.7M -97.45% | 68.2M +2,149.50% | |
Diluted Weighted Average Shares | 4.0M -95.33% | 85.0M +4,791.03% | 1.7M -97.45% | 68.2M +2,149.50% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 12,088 -42.67% | 21,085 +109.86% | 10,047 +147.04% | 4,067 +80.35% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 12,088 -42.67% | 21,085 +109.86% | 10,047 +147.04% | 4,067 +80.35% | |
Total Current Assets | 8.4M +32,732.11% | 25,441 +33.63% | 19,039 +26.67% | 15,030 +127.87% | |
Accumulated Depreciation | 25,078 -1.82% | 25,543 +1.64% | 25,130 -5.53% | 26,600 +9.16% | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | 302 -85.07% | 2,023 -52.46% | |
Total Long-Term Assets | 291,773 +975.98% | 27,117 +8,879.14% | 302 -85.07% | 2,023 -52.46% | |
Total Assets | 19.6M +27,028.87% | 72,365 +19.95% | 60,328 -26.11% | 81,651 +523.24% | |
Income Taxes Payable | N/A N/A | N/A N/A | 84,000 0.00% | 84,000 +236.00% | |
Total Short-Term Debt | 1.1M +24.24% | 870,267 +90.92% | 455,819 -55.09% | 1.0M +54.27% | |
Total Current Liabilities | 5.6M +47.08% | 3.8M +20.09% | 3.2M +3.11% | 3.1M -0.57% | |
Total Long-Term Debt | 105,627 +80.12% | 58,642 -88.16% | 495,469 -55.54% | 1.1M +46.62% | |
Total Long-Term Liabilities | 147,376 +151.31% | 58,642 +204.19% | 19,278 -54.45% | 42,319 -94.18% | |
Total Liabilities | 5.7M +48.66% | 3.9M +21.21% | 3.2M +2.33% | 3.1M +0.80% | |
Retained Earnings | -125.6M +88.34% | -66.7M +3.11% | -64.7M +5.08% | -61.6M +5.77% | |
Total Stockholders Equity | N/A N/A | -3.8M +21.23% | -3.1M +3.09% | -3.0M -1.43% | |
Total Shares Outstanding | 11.6M -97.57% | 478.8M +7,838.69% | 6.0M -97.26% | 220.4M +1,467.73% | |
Cash Flow | |||||
Cash from Operating Activities | -405,168 -56.67% | -935,118 -15.39% | -1.1M -23.05% | -1.4M +25.41% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 490,756 -47.90% | 941,894 -15.43% | 1.1M -25.29% | 1.5M +40.90% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -598.08% -78.20% | -2,743.97% -26.79% | -3,747.83% -33.20% | -5,610.62% +29.51% | |
Return on Equity | N/A N/A | 52.80% -39.07% | 86.65% -0.72% | 87.28% +21.09% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 1.50 +22,249.25% | 0.007 +11.67% | 0.006 +22.45% | 0.005 +133.33% | |
Cash Ratio | 0.002 -60.71% | 0.006 +75.00% | 0.003 +146.15% | 0.001 +85.71% | |
Debt-to-Equity Ratio | N/A N/A | -0.25 -19.46% | -0.31 -56.67% | -0.70 +52.35% | |
Debt-to-Assets Ratio | 0.06 -99.53% | 12.84 -18.60% | 15.77 -39.54% | 26.08 -75.91% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow